Logo image of CBON

VANECK CHINA BOND ETF (CBON) Stock Overview

USA - NYSEARCA:CBON - US92189F3799 - ETF

22.425 USD
+0 (+0.02%)
Last: 9/16/2025, 8:04:01 PM
Fundamental Rating

6

CBON gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. CBON has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on CBON. CBON also has an excellent dividend rating. This makes CBON very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CBON had positive earnings in the past year.
CBON had a positive operating cash flow in the past year.
CBON had positive earnings in each of the past 5 years.
Each year in the past 5 years CBON had a positive operating cash flow.
CBON Yearly Net Income VS EBIT VS OCF VS FCFCBON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

CBON has a better Return On Assets (4.39%) than 76.25% of its industry peers.
Looking at the Return On Equity, with a value of 8.81%, CBON is in the better half of the industry, outperforming 73.75% of the companies in the same industry.
CBON's Return On Invested Capital of 8.17% is fine compared to the rest of the industry. CBON outperforms 72.50% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CBON is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
CBON Yearly ROA, ROE, ROICCBON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CBON has a better Profit Margin (5.84%) than 78.75% of its industry peers.
CBON's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 10.65%, CBON is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
CBON's Operating Margin has been stable in the last couple of years.
CBON has a Gross Margin of 27.60%. This is in the better half of the industry: CBON outperforms 72.50% of its industry peers.
CBON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
CBON Yearly Profit, Operating, Gross MarginsCBON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CBON is still creating some value.
The number of shares outstanding for CBON has been reduced compared to 1 year ago.
Compared to 5 years ago, CBON has less shares outstanding
CBON has a worse debt/assets ratio than last year.
CBON Yearly Shares OutstandingCBON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CBON Yearly Total Debt VS Total AssetsCBON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.33 indicates that CBON is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.33, CBON perfoms like the industry average, outperforming 42.50% of the companies in the same industry.
CBON has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as CBON would need 6.05 years to pay back of all of its debts.
CBON has a better Debt to FCF ratio (6.05) than 65.00% of its industry peers.
CBON has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
CBON's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. CBON outperforms 67.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 2.33
ROIC/WACC1.28
WACC6.38%
CBON Yearly LT Debt VS Equity VS FCFCBON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.80 indicates that CBON should not have too much problems paying its short term obligations.
CBON has a Current ratio of 1.80. This is comparable to the rest of the industry: CBON outperforms 56.25% of its industry peers.
CBON has a Quick Ratio of 1.12. This is a normal value and indicates that CBON is financially healthy and should not expect problems in meeting its short term obligations.
CBON has a Quick ratio of 1.12. This is comparable to the rest of the industry: CBON outperforms 55.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
CBON Yearly Current Assets VS Current LiabilitesCBON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

CBON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.28%.
The Earnings Per Share has been growing slightly by 1.64% on average over the past years.
CBON shows a decrease in Revenue. In the last year, the revenue decreased by -3.62%.
Measured over the past years, CBON shows a small growth in Revenue. The Revenue has been growing by 2.41% on average per year.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

Based on estimates for the next years, CBON will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.31% on average per year.
The Revenue is expected to grow by 2.56% on average over the next years.
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CBON Yearly Revenue VS EstimatesCBON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
CBON Yearly EPS VS EstimatesCBON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.69, the valuation of CBON can be described as very reasonable.
Based on the Price/Earnings ratio, CBON is valued cheaper than 85.00% of the companies in the same industry.
CBON is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 5.10, the valuation of CBON can be described as very cheap.
CBON's Price/Forward Earnings ratio is rather cheap when compared to the industry. CBON is cheaper than 86.25% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, CBON is valued rather cheaply.
Industry RankSector Rank
PE 8.69
Fwd PE 5.1
CBON Price Earnings VS Forward Price EarningsCBON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CBON's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CBON is cheaper than 86.25% of the companies in the same industry.
75.00% of the companies in the same industry are more expensive than CBON, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.85
EV/EBITDA 3.52
CBON Per share dataCBON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBON has a very decent profitability rating, which may justify a higher PE ratio.
CBON's earnings are expected to grow with 16.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)5.29
EPS Next 2Y19.47%
EPS Next 3Y16.31%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.38%, CBON is a good candidate for dividend investing.
CBON's Dividend Yield is a higher than the industry average which is at 3.89.
CBON's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.38%

5.2 History

The dividend of CBON is nicely growing with an annual growth rate of 7.84%!
CBON has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.84%
Div Incr Years0
Div Non Decr Years0
CBON Yearly Dividends per shareCBON Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

62.40% of the earnings are spent on dividend by CBON. This is not a sustainable payout ratio.
CBON's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
CBON Yearly Income VS Free CF VS DividendCBON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
CBON Dividend Payout.CBON Dividend Payout, showing the Payout Ratio.CBON Dividend Payout.PayoutRetained Earnings

VANECK CHINA BOND ETF

NYSEARCA:CBON (9/16/2025, 8:04:01 PM)

22.425

+0 (+0.02%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners39.91%
Inst Owner Change-31.06%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap15.83B
Analysts80.87
Price Target26.96 (20.22%)
Short Float %0%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield 4.38%
Yearly Dividend1.59
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-02 2025-09-02 (0.0299)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.36%
PT rev (3m)7.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.31%
EPS NY rev (3m)-9.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE 8.69
Fwd PE 5.1
P/S 0.5
P/FCF 10.85
P/OCF 3.98
P/B 0.76
P/tB 1.03
EV/EBITDA 3.52
EPS(TTM)2.58
EY11.51%
EPS(NY)4.4
Fwd EY19.62%
FCF(TTM)2.07
FCFY9.22%
OCF(TTM)5.64
OCFY25.15%
SpS44.58
BVpS29.55
TBVpS21.75
PEG (NY)0.38
PEG (5Y)5.29
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 2.33
F-Score5
WACC6.38%
ROIC/WACC1.28
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y22.75%
EPS Next 2Y19.47%
EPS Next 3Y16.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year66.93%
EBIT Next 3Y23.28%
EBIT Next 5Y17.51%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%